CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, announced today that Chairman of the Board, Daniel Burns and CEO, Robert McCullough Jr. have recently invested $600,000 and $200,000 respectively in the company. McCullough and Burns filed a Form 4 and Burns additionally filed a Form 3, with the SEC, which details the terms of their individual investments. Both Burns and McCullough have helped fund the Company during its recent turn-around and collectively own approximately 10% of CytoCore’s common shares outstanding.
